| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibitors in ccRCC: a retrospective analysis of JAVELIN Renal 101 and checkmate-009/010/025 trials
|
Liu, Kan
|
|
|
72 |
8 |
p. 2557-2572
|
artikel
|
| 2 |
Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer
|
Yamaki, Hidekiyo
|
|
|
72 |
8 |
p. 2799-2812
|
artikel
|
| 3 |
Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expression
|
Furuya, Tatsuo
|
|
|
72 |
8 |
p. 2585-2596
|
artikel
|
| 4 |
Characterizing the tumor immune microenvironment of ependymomas using targeted gene expression profiles and RNA sequencing
|
de Koning, W.
|
|
|
72 |
8 |
p. 2659-2670
|
artikel
|
| 5 |
Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors
|
Himuro, Hidetomo
|
|
|
72 |
8 |
p. 2829-2840
|
artikel
|
| 6 |
Correction to: IL‑17A promotes fatty acid uptake through the IL‑17A/IL‑17RA/ p‑STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte‑rich microenvironment
|
Yu, Chunyan
|
|
|
72 |
8 |
p. 2875-2877
|
artikel
|
| 7 |
Correction to: Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis
|
Liu, Guanfang
|
|
|
72 |
8 |
p. 2873
|
artikel
|
| 8 |
Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy
|
Inoue, Yusuke
|
|
|
72 |
8 |
p. 2717-2728
|
artikel
|
| 9 |
Cytotoxicity of CD19-CAR-NK92 cells is primarily mediated via perforin/granzyme pathway
|
Althaus, Jonas
|
|
|
72 |
8 |
p. 2573-2583
|
artikel
|
| 10 |
Engineered murine IL-21-secreting leukemia cells induce granzyme B+ T cells and CD4+CD44+CD62L− effector memory cells while suppressing regulatory T cells, leading to long-term survival
|
Berger, Alexandra
|
|
|
72 |
8 |
p. 2597-2612
|
artikel
|
| 11 |
Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides
|
Stegmann, Toon
|
|
|
72 |
8 |
p. 2851-2864
|
artikel
|
| 12 |
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12
|
Franks, S. Elizabeth
|
|
|
72 |
8 |
p. 2783-2797
|
artikel
|
| 13 |
Identification of a novel immune checkpoint molecule V-set immunoglobulin domain-containing 4 that leads to impaired immunity infiltration in pancreatic ductal adenocarcinoma
|
Jiang, Yongsheng
|
|
|
72 |
8 |
p. 2701-2716
|
artikel
|
| 14 |
Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide
|
Naoe, Tomoki
|
|
|
72 |
8 |
p. 2865-2871
|
artikel
|
| 15 |
Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-cell RNA-sequencing
|
Jang, Sung Ill
|
|
|
72 |
8 |
p. 2757-2768
|
artikel
|
| 16 |
Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterations
|
Shimoda, Yukiko
|
|
|
72 |
8 |
p. 2613-2621
|
artikel
|
| 17 |
Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology
|
Panni, Usman Y.
|
|
|
72 |
8 |
p. 2813-2827
|
artikel
|
| 18 |
Massively recruited sTLR9+ neutrophils in rapidly formed nodules at the site of tumor cell inoculation and their contribution to a pro-tumor microenvironment
|
Kou, Mengyuan
|
|
|
72 |
8 |
p. 2671-2686
|
artikel
|
| 19 |
Nervous regulation: beta-2-adrenergic signaling in immune homeostasis, cancer immunotherapy, and autoimmune diseases
|
Thapa, Sagarina
|
|
|
72 |
8 |
p. 2549-2556
|
artikel
|
| 20 |
Phase I study of MSB2311, a novel pH-dependent anti-PD-L1 monoclonal antibody, treating patients with advanced solid tumors and lymphoma
|
Zhang, Qi
|
|
|
72 |
8 |
p. 2729-2739
|
artikel
|
| 21 |
Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients
|
Bordignon, María B.
|
|
|
72 |
8 |
p. 2687-2700
|
artikel
|
| 22 |
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas
|
Toulemonde, E.
|
|
|
72 |
8 |
p. 2649-2657
|
artikel
|
| 23 |
Self-assembled nanoparticles based on DNA origami and a nitrated T helper cell epitope as a platform for the development of personalized cancer vaccines
|
Kang, Yanliang
|
|
|
72 |
8 |
p. 2741-2755
|
artikel
|
| 24 |
Sequential CAR T cell and targeted alpha immunotherapy in disseminated multiple myeloma
|
Awuah, Dennis
|
|
|
72 |
8 |
p. 2841-2849
|
artikel
|
| 25 |
Single-center phase 2 study of PD-1 inhibitor combined with DNA hypomethylation agent + CAG regimen in patients with relapsed/refractory acute myeloid leukemia
|
Gao, Xiao-Ning
|
|
|
72 |
8 |
p. 2769-2782
|
artikel
|
| 26 |
Switchable CAR T cell strategy against osteosarcoma
|
Hidalgo, Laura
|
|
|
72 |
8 |
p. 2623-2633
|
artikel
|
| 27 |
The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasms
|
Shibamiya, Asuka
|
|
|
72 |
8 |
p. 2635-2648
|
artikel
|
Tijdschrift beschrijving